Do Mounjaro side effects last? Long-term use, lasting effects and stopping, explained by a doctor

  • Published:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 48 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Do Mounjaro side effects last? Long-term use, lasting effects and stopping, explained by a doctor

Many people worry: “Will Mounjaro’s side effects stay with me in the future?” “Is it okay to keep using it for more than a year?” “Will stopping it harm my body?” In short, at present there are no symptoms for which a causal link to permanent lasting effects has been established, but there is also not enough data to say for certain that it is safe over 10 or 20 years.

In this article, based on the electronic package insert and RMP from the PMDA (Pharmaceuticals and Medical Devices Agency) as of May 2026, the 3-year SURMOUNT-1 trial, and the SURMOUNT-4 trial, which looked at stopping treatment, we summarize what is known about future side effects, lasting effects, and changes after stopping Mounjaro (generic name: tirzepatide).

Key points firstBusy? Just read this part

  • At present, no causal link has been established showing that Mounjaro leaves permanent lasting effects in humans.
  • On the other hand, the available clinical trials last a few years at most, and very long-term effects 10 or 20 years later are not yet known.
  • Side effects such as nausea, diarrhea and constipation tend to occur when starting treatment or increasing the dose. Severe abdominal pain, repeated vomiting, jaundice, difficulty breathing and similar symptoms require prompt medical attention.
  • It has not been confirmed that the drug leaves lasting effects on the body after stopping, but your appetite and weight may come back. Don’t stop on your own—make a plan with your doctor for maintaining your weight after weight loss.

Do Mounjaro side effects last? What is known and what is not

Clinical trials lasting a few years have not identified any new safety signals, but very long-term effects remain uncertain. It is not appropriate to state flatly either that “there are definitely no lasting effects” or that “long-term use is dangerous.”

What is known at present
Gastrointestinal symptoms such as nausea, diarrhea and constipation are relatively common and tend to occur when starting treatment or increasing the dose
There are risks that are not common but can become serious, such as acute pancreatitis, biliary disease, bowel obstruction (ileus) and severe allergic reactions
A 176-week trial in participants with obesity and prediabetes identified no new safety signals
Weight tends to come back after stopping
What is not yet known
Safety when used over 10 or 20 years
To what extent the thyroid C-cell tumors seen in animal studies represent a risk in humans
Very long-term safety in healthy people using it for cosmetic purposes, and in Japanese people
Who is more likely to maintain their weight after stopping, and the best way to end treatment

In the PMDA Risk Management Plan (RMP), hypoglycemia and acute pancreatitis are monitored as “important identified risks,” and thyroid C-cell tumors, pancreatic cancer, acute biliary disease, bowel obstruction (ileus), anaphylaxis and angioedema, among others, as “important potential risks.” A potential risk does not mean “a causal link has been confirmed”; it means a risk for which information needs to continue to be collected.

Is it okay to use Mounjaro for more than a year? Results of long-term trials

Continuing treatment assumes that a doctor checks whether it is appropriate for you and how you are doing, and monitors side effects. There is no rule that “it becomes dangerous across the board after 1 year.” However, being able to use it long term is not the same as saying everyone should use it long term.

TrialParticipants and durationFindingsCaveats for interpretation
SURMOUNT-1 long-term analysisParticipants with obesity and prediabetes; 176 weeks + 17 weeks after stoppingIn the treatment groups, mean weight change at 176 weeks was −12.3% to −19.7% depending on dose. Most gastrointestinal symptoms were mild to moderate and occurred mainly during the dose escalation phase in the first 20 weeks. No new safety signals were identifiedResults from trial participants with prediabetes; safety over 10 or 20 years is not known
SURMOUNT-4Participants with obesity or overweight; 88 weeks in totalThe group switched to placebo after 36 weeks regained an average of 14.0% of body weight over the following 52 weeks. The group that continued lost an average of a further 5.5%This trial does not show that stopping causes “lasting effects”; it shows how likely weight regain is
SURPASS-CVOT13,165 patients with type 2 diabetes and atherosclerotic cardiovascular diseaseNon-inferiority to dulaglutide was confirmed on a composite of cardiovascular death, myocardial infarction and strokeSuperiority was not shown, and the results cannot be applied directly to healthy people seeking weight loss

Key point

Long-term data are increasing, but you cannot say “there were no problems for 3 years, so it will definitely be safe in the future.” It is important to keep checking your medical history, other medications, the speed of weight loss and your nutritional status from before you start.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

When should you be careful? The typical course of common side effects

Gastrointestinal symptoms such as nausea, diarrhea, constipation, vomiting and abdominal discomfort tend to occur right after starting treatment or after a dose increase. In long-term trials, too, most gastrointestinal symptoms were seen during the dose escalation phase. However, it is dangerous to keep putting up with symptoms, assuming “they will definitely go away with time.”

Symptoms and courseBasic response
Mild nausea, constipation, diarrhea, abdominal discomfortDon’t eat large amounts at once and avoid fatty meals. If symptoms continue, consult your prescribing doctor without waiting for your next dose
Unable to keep fluids down, repeated vomiting, passing little urineContact a medical institution promptly, as there is a risk of dehydration and worsening kidney function
Severe or persistent upper abdominal pain, pain radiating to the backStop the medication and see a doctor promptly, as this may be acute pancreatitis
Upper right abdominal pain, fever, jaundiceSee a doctor, as this may be gallstones, cholecystitis or a similar condition
Severe constipation, abdominal bloating, vomiting, unable to pass stool or gasSee a doctor promptly, as this may be bowel obstruction (ileus)

Side effects and lasting effects people worry about, explained one by one

Does it strain the pancreas? The link with acute pancreatitis and pancreatic cancer

Acute pancreatitis is a serious adverse reaction that the electronic package insert and RMP warn about. If you have persistent severe abdominal pain, do not wait until your next appointment. On the other hand, pancreatic cancer is a “potential risk” in the RMP, and it has not been established that Mounjaro causes pancreatic cancer in humans. If you have a history of pancreatitis, be sure to tell your doctor before starting.

Could it cause thyroid cancer?

An increase in thyroid C-cell tumors was seen in studies in rats, but the effect in humans is unknown. There is no evidence that “you will definitely get thyroid cancer in the future.” If you have a persistent lump in your neck, hoarseness or difficulty swallowing, consult your doctor. This does not mean everyone needs a calcitonin test or thyroid ultrasound; whether testing is needed is decided based on your medical history and symptoms.

Can Mounjaro cause depression? The link with psychiatric symptoms

In January 2026, the US FDA comprehensively evaluated GLP-1 receptor agonists and announced that no increased risk of suicidal thoughts or suicidal behavior was found. There is no evidence to state definitively that Mounjaro causes depression. However, other factors are possible, such as undernutrition during weight loss, feeling physically unwell, or a pre-existing mental health condition. If you notice changes such as low mood, insomnia, severe anxiety or thoughts of self-harm, don’t try to judge for yourself whether they are related to the medication—consult a medical institution right away.

Will hair loss or thinning hair last into the future?

When you lose a lot of weight in a short time, hair loss may increase due to factors such as poor nutrition and physical stress. It has not been confirmed that tirzepatide permanently damages hair roots, but if hair loss continues, it needs to be assessed, including the speed of weight loss, your intake of nutrients such as protein and iron, thyroid function, and other diseases and medications. Consult your doctor before taking large amounts of supplements on your own.

Can loss of muscle mass be a lasting effect?

When you lose weight, you may lose not only fat but also lean body mass. Lean body mass does not mean muscle alone, but you need to watch for loss of muscle strength in situations such as eating extremely little, losing weight rapidly, or not doing strength exercise. Check not only your weight but also how much you eat, your activity level and your muscle strength, and if your health is stable, include reasonable strength training.

What about pregnancy and future pregnancy?

If you are pregnant, may be pregnant, wish to become pregnant, or are breastfeeding, be sure to tell your doctor before starting or as soon as you find out. There are not enough safety data on use during pregnancy in humans. Future infertility has not been confirmed, but avoid both continuing on your own judgment because “I want to get pregnant later, so it’s fine” and stopping suddenly “because I’m worried”—discuss a plan with your prescribing doctor.

Can Mounjaro side effects be fatal?

It is not possible to say simply that “using Mounjaro causes death.” On the other hand, conditions such as acute pancreatitis, severe hypoglycemia, anaphylaxis, bowel obstruction (ileus) and worsening kidney function due to dehydration can become serious if left untreated. It is important not to use personally imported medication or medication obtained from someone else, and not to put up with severe symptoms.

What happens after stopping Mounjaro? Rebound weight gain is not a lasting side effect

After stopping the medication, your appetite may return and you may regain weight. In SURMOUNT-4, the group switched to placebo after 36 weeks of treatment regained an average of 14.0% of body weight over the following 52 weeks. Rather than a “lasting effect” of the drug damaging the body, it is more appropriate to see this as the return of the appetite and weight regulation that the drug had been suppressing.

When considering stopping, check at least the following with your prescribing doctor:

  • Your reason for stopping or adjusting the dose (side effects, reaching your goal, cost, wishing to become pregnant, etc.)
  • Rules for meal portions and snacks if your appetite returns
  • Weekly weight changes and when to come back for a visit
  • How to maintain your weight, including protein intake, exercise and sleep
  • If you are being treated for diabetes, adjustment of blood sugar and other medications

Reasons you may need to stop Mounjaro and symptoms to report right away

Whether to continue Mounjaro is not decided only by whether you are losing weight. In the following cases, contact your prescribing doctor before injecting your next dose on your own judgment.

  • Severe abdominal pain, pain radiating to the back, or repeated vomiting
  • Unable to keep fluids down, reduced urine output, or severe weakness
  • Unable to pass stool or gas, with abdominal bloating and vomiting
  • Rash, swelling of the face or throat, or difficulty breathing
  • Cold sweats, palpitations, lightheadedness, or feeling dazed or confused
  • Barely able to eat, continuing rapid weight loss, or a clear loss of muscle strength
  • You find out you are pregnant, wish to become pregnant, or have surgery or a procedure involving sedation scheduled

Depending on how urgent the symptoms are, go to an emergency medical facility without waiting to contact your prescribing doctor.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

Monitoring items to check during long-term use

Not everyone has the same tests at the same frequency. Your doctor decides based on your symptoms, whether you have diabetes, other medications, kidney function, medical history and so on.

ItemPurpose
Weight, BMI, waist circumference, food intake, muscle strength and activity levelCheck the speed of weight loss, undernutrition and loss of muscle strength
Nausea, vomiting, constipation, diarrhea, abdominal pain, jaundiceCheck for signs of gastrointestinal disorders, dehydration, pancreatitis, biliary disease and bowel obstruction (ileus)
Blood sugar and HbA1cCheck treatment effect and hypoglycemia/hyperglycemia; especially important when taking diabetes medications
Kidney function, electrolytes, etc.Assessed when dehydration or worsening kidney function due to vomiting or diarrhea is suspected
Eye symptomsIn people with diabetic retinopathy, watch for changes associated with rapid improvement in blood sugar
Mood, sleep and quality of lifeAssessed taking into account not only the medication but also undernutrition, physical condition and past illnesses

Key point

This does not mean that pancreatic enzymes, calcitonin, gallbladder ultrasound and so on are checked routinely and regularly in everyone without symptoms. Rather than adding unnecessary tests, it is important to choose the tests needed based on your symptoms and background.

In Japan, Mounjaro and Zepbound have different approved indications

Mounjaro and Zepbound both contain the active ingredient tirzepatide. However, in Japan, Mounjaro is approved for type 2 diabetes and Zepbound for obesity disease meeting certain criteria, among others, so the approved indications differ by brand name. “Same ingredient, same use” does not necessarily apply.

Using Mounjaro for weight loss is a use that differs from its approved indications in Japan, and it is self-pay treatment. Make your choice after receiving an explanation of whether the treatment is suitable for you, what effects can be expected, known side effects, alternative treatments and costs, and once you are satisfied.

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

FAQ

QIf I haven’t had any side effects from Mounjaro, will it be safe in the future too?
A

Having no side effects now is a good sign, but it does not guarantee future safety. Nor does having no side effects mean the medication isn’t working. Continue to see your doctor after dose increases and when your health changes.

QWill using Mounjaro cause diabetes in the future?
A

It has not been shown that Mounjaro causes diabetes in the future. In the 176-week SURMOUNT-1 long-term analysis in participants with obesity and prediabetes, type 2 diabetes developed in 1.3% of the treatment groups and 13.3% of the placebo group. However, these are trial results during treatment and do not show lifelong prevention after stopping.

QWill I build up a tolerance if I use it for more than a year?
A

A “plateau,” where weight loss slows down, can happen, but it does not immediately mean the medication has stopped working or become dangerous. We check your intake, activity level, target weight, dose and side effects, and review the treatment plan rather than assuming a dose increase.

QIs Mounjaro a medication I have to take for life?
A

Not everyone needs to take it for life. Diabetes and obesity disease may require chronic management, but how long to continue is decided individually based on effectiveness, side effects, goals, complications, cost and your own wishes. Rather than stopping suddenly on your own, discuss with your doctor, including a plan for maintaining your weight after treatment ends.

Not sure? Talk to us

No consultation fee (first & follow-up visits)Online consultation available

Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)

See prices

Summary | Because the future is uncertain, review your treatment regularly

At present, no causal link has been established showing that Mounjaro leaves permanent lasting effects in humans. A 3-year long-term trial identified no new safety signals, but there are no data that allow us to say for certain that it is safe 10 or 20 years ahead.

What matters is that people who need it use it under a doctor’s supervision, with checks for gastrointestinal symptoms, pancreatitis and biliary disease, bowel obstruction (ileus), hypoglycemia, allergies, dehydration, nutritional status and so on. Anticipate weight regain after stopping, and plan your diet, exercise and visits from the time you start the medication.

References and official sources

  1. Pharmaceuticals and Medical Devices Agency (PMDA): “Mounjaro Subcutaneous Injection Ateos – prescription drug information” (Japanese) (electronic package insert: May 19, 2026)
  2. PMDA: “Mounjaro / Zepbound Risk Management Plan (RMP)” (Japanese)
  3. Jastreboff AM, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025;392:958-971.
  4. Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity. JAMA. 2024;331(1):38-48.
  5. Nicholls SJ, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. N Engl J Med. 2025;393:2409-2420.
  6. U.S. Food and Drug Administration. FDA’s Evaluation Did Not Identify an Increased Risk of Suicidal Ideation or Behavior With GLP-1 RA Medications. 2026.

Who to contact if you have side effects | When to seek medical care

If you have any of the following symptoms, do not wait and see on your own—please contact us. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but in rare cases they can be serious.

SymptomPossible causeWhat to do
Ongoing nausea or vomiting and unable to keep fluids downGastrointestinal disorder, dehydration, worsening kidney functionContact us without waiting for your next dose
Severe abdominal pain (pain radiating to the back)Possible acute pancreatitisStop the medication and see a doctor promptly
Upper right abdominal pain, fever, jaundicePossible gallstones, cholecystitis or similarSee a doctor promptly
Severe abdominal bloating, vomiting, unable to pass stool or gasPossible bowel obstruction (ileus)See a doctor promptly
Cold sweats, palpitations, intense hunger, or feeling dazed or confusedHypoglycemiaTake some sugar if you can and contact us. If consciousness is impaired, consider calling an ambulance
Rash, difficulty breathing, or swelling of the face or throatPossible anaphylaxis or angioedemaGo to an emergency medical facility immediately
Contact: 0120-241-929 (hours: 9:00–18:00)

If your symptoms are severe outside these hours, please go to your nearest emergency medical facility.

Direct phone numbers for each clinic are listed on the clinic information page.

*This article is intended to provide general information and is not a substitute for diagnosis or treatment. Effects and side effects vary from person to person. Always consult your doctor before starting, increasing or stopping the medication.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine Graduated from Toho University School of Medicine and joined the Department of Internal Medicine at Keio University School of Medicine. After training in internal medicine at university and general hospitals, she has worked in obesity treatment and weight-management guidance from an internal-medicine perspective. About our medical review and editorial policy

Related articles

You may also like

Back to all articles

Last updated:

Ask our AI chat AI chat